See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Top Rated

Related Products Videos on Diabetes Health TV

Bryan Sowards with Infopia demonstrates a variety of new products

Bryan Sowards

Bryan Sowards with Infopia demonstrates a variety of new products

David Speaks About His Experience in the Diabetes Investment Field

David Kliff

David Speaks About His Experience in the Diabetes Investment Field

Painless Syringes And Needles By BD

Joanna French

Painless Syringes And Needles By BD

Diabetes Health Reference Charts
Pens Archives

Pens for Diabetes

Updated 160 weeks ago
UltiMed Launches 50-Count Pen Needle

UltiMed, which offers the only pen needles assembled in the United States, has announced that it is now offering a 50-count universal-fit pen needle.

Comments 2 comments - Mar 28, 2011 - * * * * *

Insulin Needle Wins Design Prize, But You Can't Buy It in the States

The Chicago Athenaeum: Museum of Architecture has announced its 60th annual Good Design Awards, which honor "quality design of the highest form, function, and aesthetic." Guess which paragon of contemporary design won an award this year? An insulin needle. Called the NovoTwist and made by Novo Nordisk for use with insulin pens, this marvel of design has a bayonet fitting that allows "just twist" attachment and detachment to compatible pens, and an audible and tactile "click" that confirms attachment of the needle.

Comments 4 comments - Feb 1, 2011 - * * * * *


Working toward the goal of unifying patients' diabetic treatment information in a single place, the PositiveID Corporation hopes to patent a new device that monitors insulin pens. The Insulin Tracker would attach to a user's insulin pen and record the times and amounts of injections. That information would then be sent to a database that allows for comprehensive monitoring. Insulin pens come in disposable and cartridge-replaceable flavors; the tracker can be moved easily from one pen to another.

Comments 0 comments - Aug 27, 2010 - * * * * *

Apidra SoloSTAR Pen Now Available in the United States

Insulin pens have been very popular in Europe for quite some time and interest is building steadily in the United States. Many people prefer an insulin pen over the standard syringe and vial because the pens are more convenient and more accurate.  Pre-filled disposable insulin pens are the easiest of all, because you don't never have to install a new cartridge when the pen is empty-you just toss it out.

Comments 4 comments - Apr 28, 2009 - * * * * *

Insulin Pen Instead of Syringe Saves Hospital Bills For Type 2s

In a study funded by Novo Nordisk, researchers at Ohio State University have found that type 2s who move from oral meds to insulin would be wise to start with an insulin pen rather than a syringe.

Comments 16 comments - Mar 21, 2009 - * * * *

Insulin For Type 2 Diabetes: Who, When, And Why?

Physicians who treat people with type 2 diabetes face difficult choices when selecting the best medical therapy for each patient. The decision process is further complicated by the fact that because type 2 diabetes is a progressive disease, therapeutic agents that were initially successful may fail five or ten years later.

Comments 151 comments - Mar 20, 2009 - * * * * *

Novo Nordisk’s Improved FlexPen® Now Available in the U.S.

Novo Nordisk has redesigned the FlexPen®, the number one selling pre-filled insulin pen in the world, to not only require less force when pushing the button to inject insulin, but also to clearly identify each type of insulin with prominent color branding. The FlexPen® is available with three Novo Nordisk insulin products: Levemir® (insulin detemir [rDNA origin] injection); NovoLog® (insulin aspart [rDNA origin] injection); and NovoLog® Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]).

Comments 6 comments - Mar 18, 2009 - * * * * *

Readers Challenge Insulin Manufacturers: Help Us Avoid Near-Fatal Mistakes!
Readers Challenge Insulin Manufacturers: Help Us Avoid Near-Fatal Mistakes!

Sandy was giving her son his evening dose of NPH insulin - something she had done many times. But as she finished pushing in the plunger, she said to herself, "That shot took too long." She immediately realized that she had given Joey the wrong dose. In other words, by mistake, she had given him a potentially lethal dose of insulin.

Comments 61 comments - Dec 25, 2008 - * * * *

Amylin’s Woes Mount, Thanks to FDA Actions

The stock of Byetta manufacturer Amylin Pharmaceuticals has lost more than half of its value over the past eight weeks, thanks to FDA concerns that the type 2 treatment may be connected with the deaths from acute pancreatitis of six Byetta users. Although the FDA has not proven a direct association between fatal pancreatitis and the use of Byetta, Amylin's stock has fallen nevertheless.

Comments 0 comments - Oct 13, 2008 - * * *

Nassau Medical Center Extends Warning Over Insulin Pens

Nassau University Medical Center said it had underestimated the number of diabetes patients potentially exposed to reused insulin pens and would be sending letters to at least 840 of them, instead of 185, urging them to be tested for hepatitis C and B and HIV.

Comments 3 comments - May 22, 2008 - Not Yet Rated

Next Page »  
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.